Target intelligence / Profile preview

tRNA splicing endonuclease subunit 54 (TSEN54)

Target
TSEN54
Molecular classification
Enzyme complex subunit, RNA processing enzyme, Non-catalytic subunit
01

Overview

tRNA splicing endonuclease subunit 54 (TSEN54) is a non-catalytic subunit of the tRNA splicing endonuclease complex, an essential cellular enzyme responsible for processing pre-tRNA by removing introns at specific splice sites, which is required for the production of mature, functional tRNA molecules[1][2][3][5][6][7][10]. TSEN54 acts primarily as a structural scaffold and plays a pivotal role in substrate recognition by “measuring” the geometry of pre-tRNA, anchoring it within the multi-subunit complex and ensuring correct cleavage[2][10]. In addition to its central role in tRNA splicing, the complex is implicated in mRNA 3'-end processing and polyadenylation, and possibly other RNA-processing events[1][3][5][6]. Mutations in TSEN54 cause severe neurodevelopmental diseases known as pontocerebellar hypoplasias (PCH), especially types 2A, 4, and 5, which present with profound brain abnormalities, intellectual disability, delayed development, and other neurological deficits[1][7][9]. The pathological mechanism involves failure of tRNA (and potentially mRNA) processing, leading to neurodegeneration and impaired brain growth.

Other names
tRNA-splicing endonuclease subunit Sen54SEN54HsSEN54SEN54LTSEN54 homologtRNA-intron endonuclease Sen54PCH2APCH4PCH5sen54TSEN54phTSEN54E7EN92J3KRC5
02

Biological functions

tRNA intron removal (splicing)RNA processingpre-mRNA 3'-end processingstructural scaffold for tRNA splicing endonuclease complex
03

Disease associations

Neurodevelopmental disease, specifically pontocerebellar hypoplasia types 2A, 4, and 5possibly other “TSENopathies”
04

Safety considerations

Given TSEN54’s critical role in RNA processing and neurodevelopment, loss of function is associated with severe, often fatal, developmental brain disorders (e.g., pontocerebellar hypoplasia); thus, targeting TSEN54 is likely not a therapeutic option and manipulation poses high risk of toxicity and lethality
05

Biomarkers

Mutations in TSEN54 (especially homozygous loss-of-function variants) are biomarkers for pontocerebellar hypoplasia subtypes PCH2, PCH4, PCH5

Beyond the preview

Go deeper on tRNA splicing endonuclease subunit 54 (TSEN54).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA splicing endonuclease subunit 54 (TSEN54).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call